SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Por um escritor misterioso

Descrição

Rapid antidepressant effects associated with ketamine have shifted the landscape for the
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
The Patient Experience of Recovery Following Anti-NMDA Receptor
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Molecular mechanisms underlying the antidepressant actions of
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Targeting NMDA receptors in neuropsychiatric disorders by drug
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Cannabinoids and Vanilloids in Schizophrenia
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
mGlu1 potentiation enhances prelimbic somatostatin interneuron
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Does mismatch negativity have utility for NMDA receptor drug
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA receptor trafficking in synaptic plasticity and
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Dual action of amitriptyline on NMDA receptors: enhancement of Ca
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
SciELO - Brazil - Does mismatch negativity have utility for NMDA
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Neuroprogression in schizophrenia: Pathways underpinning
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Using the pharmacology of latent inhibition to model domains
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA receptor subunit diversity: impact on receptor properties
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Depolarizing GABAA current in the prefrontal cortex is linked with
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA Antagonists and Their Role in the Management of Bipolar
de por adulto (o preço varia de acordo com o tamanho do grupo)